Washington: Observing the evolution of a particular type of antibody in an infected HIV-1 patient has provided insights that will enable vaccination strategies that mimic the actual antibody development within the body.The kind of antibody studied is called a broadly cross-reactive neutralizing antibody, and details of its generation could provide a blueprint for effective vaccination, the study`s researchers said.
Exclusive: No questions on Modi, says Joshi
`No point in Modi apologising for Gujarat riots`
Salman killed Blackbucks: Forest official
Stop govt from appointing new Army chief: BJP to Election Commission